Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Sep 13;20(3):281-2.
doi: 10.1016/j.ccr.2011.08.020.

Ras, ROS and proteotoxic stress: a delicate balance

Affiliations
Comment

Ras, ROS and proteotoxic stress: a delicate balance

Wanping Xu et al. Cancer Cell. .

Abstract

Ras-deregulated cells require reactive oxygen species for proliferation. They survive the resultant proteotoxic stress by maintaining sufficient levels of reduced glutathione and optimally functioning stress response machinery. In this issue of Cancer Cell, De Raedt et al. identify a novel strategy that utilizes this dependency to cause cell death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The relationship between Ras-driven signaling pathways, ROS, Hsp90, and ER stress. Ras-driven proliferation requires ROS buffering of Ras-activated ERK1/2 activity (1). ROS level is regulated in part by reduced glutathione (GSH), requiring sufficient NADPH generated by G6PD-mediated glucose oxidation via the pentose phosphate pathway (2). G6PD expression is regulated by mTOR, a component of a second Ras-driven signaling pathway that is inhibited by rapamycin (3). Hsp90 buffers cellular ROS and is essential for stabilization and activity of the ER transmembrane kinases PERK and IRE1, two components of the ER stress response machinery. The Hsp90 inhibitor IPI-504 causes ROS levels to increase while also abrogating the ER stress response (4). The combination of IPI-504 and rapamycin disrupts the balance between ROS and GSH, causing catastrophic ER stress and cell death.

Comment on

References

    1. De Raedt, et al. Cancer Cell. 2011;(this issue)
    1. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11–22. - PubMed
    1. Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1–11. - PubMed
    1. Marcu MG, Doyle M, Bertolotti A, Ron D, Hendershot L, Neckers L. Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha. Mol Cell Biol. 2002;22:8506–8513. - PMC - PubMed
    1. Matallanas D, Crespo P. New druggable targets in the Ras pathway? Curr Opin Mol Ther. 2010;12:674–683. - PubMed

LinkOut - more resources